
NAD+
Nicotinamide Adenine Dinucleotide
NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme central to mitochondrial energy production and DNA-repair pathways — a cornerstone compound for cellular-aging, metabolic and longevity protocols. Typical Course: A typical cycle runs 4 weeks on, 4 weeks off. It begins with a 1-week phase at a lower dose administered slowly (50mg, via IV or injection), followed by a 3-week phase at 100–500mg, given daily or every other day. Most customers notice initial effects within the first week, with results peaking around week 4. What to Expect: Improved cellular energy, mental clarity, enhanced recovery and better sleep quality. Key benefits include immediate energy effects, activation of DNA-repair pathways, broad systemic benefits and strong research backing. Considerations & Safety: Flushing is very common during IV administration, which is why it is given slowly. Common side effects include flushing and warmth (very common with IV), chest pressure during infusion, nausea, headache and muscle cramps. Seek medical attention immediately if you experience severe chest pain that does not resolve when the infusion is slowed, difficulty breathing, severe allergic reaction, or irregular heartbeat.
500 mg
99%+
1,050 AED
| Sequence | Available on request |
| Molecular Formula | C21H27N7O14P2 |
| Molecular Weight | 663.43 g/mol |
| CAS Number | 53-84-9 |
| Form | Reconstituted injection pen |
| Purity | ≥ 99%+ |
Related Compounds

Retatrutide
Triple-agonist (GLP-1 / GIP / Glucagon) metabolic peptide.
750 AED

Tirzepatide
Dual GLP-1 / GIP agonist for metabolic support.
750 AED

Retatrutide + Cagrilintide
Triple agonist + amylin analogue blend
Combined incretin + amylin pathway blend.
1,250 AED

Tesamorelin
GHRH analogue used for visceral-fat support.
750 AED